You've been diagnosed with atrial fibrillation. Your cardiologist has mentioned ablation as an option — possibly even recommended it. The appointment was short, the explanation was incomplete, and now you're at home trying to understand whether a procedure that involves threading catheters into your heart is really the right next step for you.
The honest answer is: it might be. But whether ablation is right for you specifically depends on the type of AFib you have, what your imaging shows, your age and risk profile, and how much your symptoms are affecting your quality of life. This article gives you the decision framework your cardiologist should walk you through — and the questions you should not leave that appointment without asking.
First: what type of AFib do you have?
Not all AFib is the same. The type matters enormously for treatment decisions. Most cardiologists will have classified yours, but many patients leave appointments without clearly understanding which category applies to them.
- Paroxysmal AFib: Episodes start and stop on their own, typically within 7 days. This is the most common presentation and the one where ablation has the strongest evidence for symptom benefit.
- Persistent AFib: Episodes last longer than 7 days and require medical or electrical intervention (cardioversion) to restore normal rhythm. Ablation is still an option but has lower long-term success rates.
- Long-standing persistent AFib: Continuous AFib lasting more than 12 months. Ablation has more limited evidence here; medication management is often the primary strategy.
- Permanent AFib: Where the decision has been made — by you and your cardiologist — that rhythm control is no longer the goal, and rate control (keeping your heart rate in a safe range) is the focus.
If you don't know which of these categories you fall into, that is the first thing to clarify at your next appointment.
What catheter ablation actually does
Catheter ablation for AFib works by electrically isolating the pulmonary veins — the four veins that carry oxygenated blood from the lungs into the left atrium of the heart. In most cases of paroxysmal AFib, abnormal electrical signals originating from inside or near these veins trigger the irregular heartbeat. Ablation creates a ring of scar tissue around each pulmonary vein, blocking those rogue signals from reaching the rest of the heart.
The procedure takes 2–4 hours under sedation or general anaesthesia. A catheter is inserted through a vein in the groin and threaded up to the heart. Radiofrequency energy (heat) or cryoablation (cold) is used to create the scar tissue. Most patients spend one night in hospital and recover over 1–2 weeks.
Catheter ablation for AFib has a success rate of roughly 60–80% at one year for paroxysmal AFib — meaning 20–40% of patients have AFib recurrence within a year and may need a second procedure, ongoing medication, or both. For persistent AFib, the success rates are lower. This is not a reason to avoid ablation if it's appropriate — but it's essential information for managing expectations and understanding that ablation is often not a one-time cure.
Ablation vs medication: what the evidence actually says
Catheter Ablation
- Better symptom control in paroxysmal AFib
- Some patients achieve rhythm control without ongoing medication
- May reduce AFib burden (frequency and duration)
- CABANA trial showed quality of life benefit
- 30–40% recurrence rate at 1 year
- Procedural risks: stroke, cardiac tamponade, pulmonary vein stenosis (rare but real)
- May still need medication afterward
- Long wait times in Canada public system
Medication Management
- No procedural risk
- Rate control with beta-blockers is well-established
- Rhythm control with anti-arrhythmics is viable
- Anti-coagulation (blood thinners) mandatory either way
- Ongoing medication with side effects
- Anti-arrhythmic drugs have significant side effect profiles
- Symptoms may persist if rate control is imperfect
- Long-term structural changes to atrium can progress
The landmark CABANA trial (2019), the largest randomized trial comparing catheter ablation to medication for AFib, found that ablation did not significantly reduce the primary composite endpoint of death, disabling stroke, serious bleeding, or cardiac arrest compared to medication alone — but it did significantly improve quality of life and reduce AFib recurrence. The interpretation matters: ablation is primarily a quality-of-life intervention, not a mortality intervention. If your AFib is well-controlled on medication and you are asymptomatic, the case for ablation is weaker.
Your CHA₂DS₂-VASc score — why it matters regardless of which path you choose
Before any decision about ablation or medication, your stroke risk needs to be calculated. Atrial fibrillation increases stroke risk because when the atria beat irregularly, blood can pool and clot — and those clots can travel to the brain. The CHA₂DS₂-VASc score calculates your annual stroke risk based on seven factors:
| Factor | Points |
|---|---|
| Congestive heart failure | 1 |
| Hypertension | 1 |
| Age 75 or older | 2 |
| Diabetes mellitus | 1 |
| Prior stroke or TIA | 2 |
| Vascular disease (prior heart attack, peripheral artery disease) | 1 |
| Age 65–74 | 1 |
| Female sex | 1 |
A score of 2 or above (1 for men) means blood thinners (anticoagulants) are recommended — regardless of whether you choose ablation or medication for rhythm/rate control. Anti-coagulation is not optional at this threshold, and ablation does not eliminate the need for it. If your cardiologist has not explicitly discussed your CHA₂DS₂-VASc score and what it means for anti-coagulation, that needs to happen before any other decision.
What tests should be reviewed before deciding on ablation
A proper evaluation before AFib ablation should include:
- Echocardiogram (echo): Assesses the size of your left atrium (enlarged atrium reduces ablation success), your ejection fraction, and any structural heart disease. Essential before ablation.
- Holter monitor (24–48 hour): Captures your AFib burden over time — how often you're in AFib, how fast your heart rate goes, whether you're in AFib continuously or intermittently. Informs whether rate control is adequate on current medication.
- CT angiography or MRI of pulmonary veins: Sometimes done pre-ablation to map the anatomy of the pulmonary veins, which vary between individuals.
- Thyroid function tests: Hyperthyroidism (overactive thyroid) is a reversible cause of AFib. If untreated, ablation will be less effective. Thyroid function should be checked and corrected before any ablation procedure.
- Sleep apnea screening: Untreated obstructive sleep apnea significantly increases AFib recurrence post-ablation. Many cardiologists will not proceed with ablation in patients with suspected undiagnosed sleep apnea.
The questions to ask your cardiologist before deciding
"Before I decide on ablation, I want to review my echocardiogram findings, discuss my CHA₂DS₂-VASc score, and understand what happens if ablation doesn't work or AFib recurs. I'd also like to understand medication management as a full alternative — including what rate control alone would look like for my profile."
A word on the wait time for ablation in Canada
In BC and Ontario, wait times for electrophysiology procedures like catheter ablation can be significant — often 6–12 months from referral to procedure date in the public system. In that window, having a clear understanding of your condition — your AFib type, your stroke risk, your imaging results — allows you to make the most of every appointment, ask the right questions when you do get in, and ensure your interim medication management is appropriate.
If you've been referred but don't yet have your appointment, or if you've received a recommendation for ablation and something doesn't feel complete about the explanation, a second opinion from a cardiologist who has reviewed your full case is entirely reasonable before committing to a procedure.